Top Page
Towa Corporation
(Frankfurt:6315)
Towa Corporation (6315) vs. S&P 500 (SPY)
Towa Corporation Business Overview & Revenue Model
Towa Corporation Financial Statement Overview
| Breakdown | |||||
| TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 57.70B | 50.47B | 53.82B | 50.67B | 29.71B | 25.26B | Gross Profit |
| 21.82B | 18.20B | 18.81B | 18.65B | 9.62B | 6.59B | EBIT |
| 11.11B | 8.66B | 10.04B | 11.51B | 3.62B | 812.24M | EBITDA |
| 12.70B | 11.87B | 12.87B | 13.71B | 5.50B | 2.24B | Net Income Common Stockholders |
| 8.48B | 6.44B | 7.35B | 8.13B | 2.66B | 368.80M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 22.18B | 20.83B | 16.55B | 12.41B | 10.69B | 10.02B | Total Assets |
| 86.46B | 87.86B | 73.47B | 71.33B | 51.79B | 43.12B | Total Debt |
| 11.77B | 14.02B | 15.87B | 10.42B | 7.81B | 9.79B | Net Debt |
| -10.41B | -6.50B | -673.48M | -1.99B | -2.88B | -230.74M | Total Liabilities |
| 25.17B | 29.43B | 25.85B | 30.21B | 20.29B | 16.11B | Stockholders Equity |
| 61.29B | 58.44B | 47.22B | 40.73B | 31.18B | 26.93B |
| Cash Flow | Free Cash Flow | ||||
| 0.00 | 8.00B | 99.81M | 1.13B | 2.62B | 3.89B | Operating Cash Flow |
| 0.00 | 9.67B | 2.83B | 6.40B | 5.31B | 6.35B | Investing Cash Flow |
| 0.00 | -2.77B | -2.75B | -6.60B | -2.77B | -2.54B | Financing Cash Flow |
| 0.00 | -3.52B | 3.96B | 1.93B | -2.24B | -1.56B |
Towa Corporation Technical Analysis
Towa Corporation Peers Comparison
Towa Corporation Corporate Events
Towa Corporation has announced key personnel changes effective April 1, 2025, involving the reassignment of executive roles within its corporate planning and production divisions. These changes are likely to enhance the company’s strategic planning capabilities and operational efficiency, potentially impacting its market position positively.
Towa Corporation announced a change in its reporting segments, renaming the ‘Fine Plastic Molding Products Business’ to ‘Medical Devices Business’ to better reflect its focus on medical devices. This change is part of the company’s medium-term management plan and will be effective from the fiscal year ending March 2025, with no impact on the classification of reporting segments.
Towa Corporation has announced its second mid-term management plan for 2026-2028, focusing on new challenges and leadership development under the theme ‘Enabling the Next Generation of Leadership with TOWA-ism’. The plan emphasizes enhancing product value, leveraging digital transformation, and investing in human resources to maintain industry leadership. It also outlines strategies for its semiconductor, medical device, and laser businesses, aiming for sustainability and market expansion.
Towa Corporation has developed a new packaging technology called Ultra narrow gap Mold Underfill, designed to enhance semiconductor packaging for next-generation HBM4 semiconductors used in generative AI. This technology allows for improved stacking of semiconductor chips, increasing productivity and quality in manufacturing processes, and is set to be implemented in new equipment with sales beginning in August.
Towa Corporation has announced a Mid-Term Management Plan Briefing Session for institutional investors and analysts, scheduled for March 28, 2025. This session will be conducted online in Japanese and will feature key company executives, including the current President and CEO, Hirokazu Okada, who is set to become the Representative Director, Chairman & CEO, and Muneo Miura, who will assume the role of Director, President Executive Officer. The briefing aims to provide insights into the company’s strategic direction and future plans, with presentation materials to be made available on the company’s website post-session.
Towa Corporation announced changes in its executive and director positions, with reappointments and new appointments aimed at strengthening its leadership team. The appointments, including a new independent director, are expected to be confirmed at the upcoming General Meeting of Shareholders, potentially impacting the company’s strategic direction and operational efficiency.
Towa Corporation has announced a change in its presidential leadership, with Muneo Miura set to become the new President effective April 1, 2025. This transition is part of the company’s strategy to achieve its ‘Towa Vision 2032’ goals, aiming to strengthen its management structure and increase corporate value.
Towa Corporation has announced a downward revision in its earnings forecast for FY2024, attributing the changes to prolonged stagnation in demand for end-use products such as smartphones and PCs, and delayed investments in consumer goods and memory semiconductors. Despite these challenges, Towa anticipates achieving record-high net sales compared to the previous fiscal year, with plans to sell investment securities to fund capital and R&D investments, aiming to strengthen its growth strategy amidst economic uncertainties.
Towa Corporation reported significant financial growth for the nine months ending December 31, 2024, with a 22.6% increase in net sales and a remarkable 65.5% rise in profits attributable to owners of the parent compared to the previous year. The company also revised its earnings forecast for the fiscal year ending March 31, 2025, reflecting continued positive growth, which indicates a strong market position and potential benefits for stakeholders.